Geovax Labs Inc
NASDAQ:GOVX 4:00:00 PM EDT
| Market Cap (Intraday) | 13.79M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.94 |
| 50-Day MA | $0.99 |
| 200-Day MA | $1.77 |
Geovax Labs Inc Stock, NASDAQ:GOVX
1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080
United States of America
Phone: +1.678.384.7220
Number of Employees: 17
Description
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.